Use of the QIAGEN GeneReader NGS system for detection of KRAS mutations, validated by the QIAGEN Therascreen PCR kit and alternative NGS platform.
Darwanto A, Hein AM, Strauss S, Kong Y, Sheridan A, Richards D, Lader E, Ngowe M, Pelletier T, Adams D, Ricker A, Patel N, Kühne A, Hughes S, Shiffman D, Zimmermann D, Te Kaat K, Rothmann T.
Darwanto A, et al. Among authors: shiffman d.
BMC Cancer. 2017 May 22;17(1):358. doi: 10.1186/s12885-017-3328-z.
BMC Cancer. 2017.
PMID: 28532404
Free PMC article.